ANVS
Annovis Bio
$9.49
Earnings Summary
Net Profits | $-9.54Mn |
Highlights
Net Profits:
Annovis Bio’s net profit fell -9.39% since last year same period to $-9.54Mn in the Q2 2023. On a quarterly growth basis, Annovis Bio has generated 2.05% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Annovis Bio post its latest quarter earnings
EPS Estimate Current Quarter | -0.57 |
EPS Estimate Current Year | -0.57 |
Highlights
EPS Estimate Current Quarter:
Annovis Bio’s earning per share (EPS) estimates for the current quarter stand at -0.57 - a 36.67% jump from last quarter’s estimates.
EPS Estimate Current Year:
Annovis Bio’s earning per share (EPS) estimates for the current year stand at -0.57.
Key Ratios
Key ratios of the Annovis Bio post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Annovis Bio’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Annovis Bio has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-14 | -0.57 | 0 | 100% |
2023-05-10 | -0.9 | 0 | 100% |
₹0 US Stocks a/c Opening Fee